Cargando…
Prime Editing for Human Gene Therapy: Where Are We Now?
Gene therapy holds tremendous potential in the treatment of inherited diseases. Unlike traditional medicines, which only treat the symptoms, gene therapy has the potential to cure the disease by addressing the root of the problem: genetic mutations. The discovery of CRISPR/Cas9 in 2012 paved the way...
Autores principales: | Godbout, Kelly, Tremblay, Jacques P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954691/ https://www.ncbi.nlm.nih.gov/pubmed/36831203 http://dx.doi.org/10.3390/cells12040536 |
Ejemplares similares
-
Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023) -
CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023) -
Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
por: Daliri, Karim, et al.
Publicado: (2017) -
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018) -
Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)